seed
Stage
1
Investors
About
Vysioneer develops AI-powered tools to analyze tumor heterogeneity at the lesion level in oncology clinical trials, enabling earlier and more precise assessment of treatment efficacy to improve cancer trial outcomes.
Explore Vysioneer's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.